Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seock-Ah Im

Showing results (11-20 of 567) with videos related to

Pageof 57
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2023
Reply to Y. Yoshitomi et alSara M Tolaney, Elisabeth De Kermadec, Patrick Cohen, et al.
Annals of Clinical and Translational Neurology|October 8, 2020
HLA-B27 association of autoimmune encephalitis induced by PD-L1 inhibitorHyeyeon Chang, Yong-Won Shin, Bhumsuk Keam, et al.
Korean Journal of Radiology|September 2, 2017
Human Epidermal Growth Factor Receptor 2 Expression in Unresectable Gastric Cancers: Relationship with CT CharacteristicsJeong Sub Lee, Se Hyung Kim, Seock-Ah Im, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 22, 2014
Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancerJosé Baselga, Javier Cortés, Seock-Ah Im, et al.
Cancer Treatment Reviews|November 4, 2017
The next era of treatment for hormone receptor-positive, HER2-negative advanced breast cancer: Triplet combination-based endocrine therapiesJavier Cortés, Seock-Ah Im, Esther Holgado, et al.
European Journal of Radiology|February 9, 2011
Magnetic resonance imaging evaluation of residual ductal carcinoma in situ following preoperative chemotherapy in breast cancer patientsHei Kyung Choi, Nariya Cho, Woo Kyung Moon, et al.
Clinical Imaging|May 3, 2003
A case of pyothorax-associated lymphoma simulating empyema necessitatisYookyung Kim, Sun Wha Lee, Hae Young Choi, et al.
Cancer Research and Treatment|December 4, 2009
Expression of cyclooxygenase-2 in human breast cancer: relationship with HER-2/neu and other clinicopathological prognostic factorsEunmi Nam, Soon Nam Lee, Seock-Ah Im, et al.
Journal of Gastroenterology and Hepatology|August 28, 2010
Clinicopathologic features and clinical outcomes of gastric cancer that initially presents with disseminated intravascular coagulation: a retrospective studyJiyoung Rhee, Sae-Won Han, Do-Youn Oh, et al.
Cancer Research and Treatment|March 30, 2021
Talazoparib Versus Chemotherapy in Patients with HER2-negative Advanced Breast Cancer and a Germline BRCA1/2 Mutation Enrolled in Asian Countries: Exploratory Subgroup Analysis of the Phase III EMBRACA TrialKyung-Hun Lee, Joohyuk Sohn, Annabel Goodwin, et al.
Pageof 57

Showing results (11-20 of 567) with videos related to

Sort By:
Pageof 57
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2023
Reply to Y. Yoshitomi et alSara M Tolaney, Elisabeth De Kermadec, Patrick Cohen, et al.
Annals of Clinical and Translational Neurology|October 8, 2020
HLA-B27 association of autoimmune encephalitis induced by PD-L1 inhibitorHyeyeon Chang, Yong-Won Shin, Bhumsuk Keam, et al.
Korean Journal of Radiology|September 2, 2017
Human Epidermal Growth Factor Receptor 2 Expression in Unresectable Gastric Cancers: Relationship with CT CharacteristicsJeong Sub Lee, Se Hyung Kim, Seock-Ah Im, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 22, 2014
Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancerJosé Baselga, Javier Cortés, Seock-Ah Im, et al.
Cancer Treatment Reviews|November 4, 2017
The next era of treatment for hormone receptor-positive, HER2-negative advanced breast cancer: Triplet combination-based endocrine therapiesJavier Cortés, Seock-Ah Im, Esther Holgado, et al.
European Journal of Radiology|February 9, 2011
Magnetic resonance imaging evaluation of residual ductal carcinoma in situ following preoperative chemotherapy in breast cancer patientsHei Kyung Choi, Nariya Cho, Woo Kyung Moon, et al.
Clinical Imaging|May 3, 2003
A case of pyothorax-associated lymphoma simulating empyema necessitatisYookyung Kim, Sun Wha Lee, Hae Young Choi, et al.
Cancer Research and Treatment|December 4, 2009
Expression of cyclooxygenase-2 in human breast cancer: relationship with HER-2/neu and other clinicopathological prognostic factorsEunmi Nam, Soon Nam Lee, Seock-Ah Im, et al.
Journal of Gastroenterology and Hepatology|August 28, 2010
Clinicopathologic features and clinical outcomes of gastric cancer that initially presents with disseminated intravascular coagulation: a retrospective studyJiyoung Rhee, Sae-Won Han, Do-Youn Oh, et al.
Cancer Research and Treatment|March 30, 2021
Talazoparib Versus Chemotherapy in Patients with HER2-negative Advanced Breast Cancer and a Germline BRCA1/2 Mutation Enrolled in Asian Countries: Exploratory Subgroup Analysis of the Phase III EMBRACA TrialKyung-Hun Lee, Joohyuk Sohn, Annabel Goodwin, et al.
Pageof 57